The Korean Practice Parameter for the Treatment of Attention-Deficit Hyperactivity Disorder(III): Pharmacologic Treatment
Journal of the Korean Academy of Child and Adolescent Psychiatry
; : 16-25, 2007.
Artigo
em Coreano
| WPRIM (Pacífico Ocidental)
| ID: wpr-154566
Biblioteca responsável:
WPRO
ABSTRACT
The objective of this review is to propose the Korean practice guideline for pharmacological treatment of attentiondeficit hyperactivity disorder(ADHD). For making the guideline, the authors used the evidence-base approaches derived from a detailed review of literature including wide range of controlled clinical trials, studies of side effects of drugs, toxicological reports, and meta-analyses published in United States and Europe, as well as inside Korea. The review committee composed of experts in ADHD in Korea has reviewed the parameter. The practice parameter for pharmacological treatment describes the use of stimulants, atomoxetine, modafinil, bupropion, tricyclic antidepressants, and alpha-adrenergic agonists and their side effects. The recommendations of pharmacological treatment are proposed at the end of the article.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Assunto principal:
Estados Unidos
/
Bupropiona
/
Agonistas alfa-Adrenérgicos
/
Comitês Consultivos
/
Europa (Continente)
/
Cloridrato de Atomoxetina
/
Coreia (Geográfico)
/
Antidepressivos Tricíclicos
Tipo de estudo:
Guia de prática clínica
País/Região como assunto:
América do Norte
/
Ásia
/
Europa
Idioma:
Coreano
Revista:
Journal of the Korean Academy of Child and Adolescent Psychiatry
Ano de publicação:
2007
Tipo de documento:
Artigo